Feasibility
Structural druggability and target accessibility assessment.
AffiniBind™ designs candidate binders with three complementary engines, and twelve quality checks, so only the most promising candidates reach the lab.
Cutting-edge pipeline from target preparation through results export, engineered for process transparency at every gate.
Structure cleaning, residue table construction, and surface characterization.
Four complementary models score every surface residue for binding potential.
High-scoring residues clustered into ranked binding patches with 3D visualization.
Three generative engines produce diverse candidates on cloud GPU infrastructure.
The AffiniBind surface fingerprinting pipeline combines ScanNet, MaSIF, MPBind, and APBS electrostatics to identify critical interface residues, validated on 223 complexes from the gold-standard DB5.5 docking benchmark with a 96.4% Top-3 patch hit rate. Read the benchmark analysis →
A rigorous six-stage progression with explicit advancement criteria at every gate, from feasibility through validated assay.
Structural druggability and target accessibility assessment.
Generative design and sequence-to-library generation.
IVTT expression and proximity assay screening.
Functional assays and off-target cross-reactivity profiling.
Validated binder delivered assay-ready with a characterized performance package.
Participate in community-driven protein design challenges and follow live candidate progress.
Submit your target requirements to initiate a feasibility review. Our engineering team will respond within two business days.
Bring us a target. We will return high-confidence, assay-aware candidates built to survive experimental validation.
Twelve screening dimensions evaluate expression, solubility, affinity, and risk.
